Sonoma Pharmaceuticals, Inc. (SNOA)

Sonoma Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Year Ending	Current	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	6	3	5	12	15	9
Market Cap Growth	-42.82%	-42.82%	-63.46%	-19.52%	77.22%	-22.62%
Enterprise Value	3	0	2	6	14	6
PE Ratio	-	-0.54	-0.88	-2.44	-3.91	-2.63
PS Ratio	0.46	0.20	0.34	0.98	0.83	0.49
PB Ratio	0.95	0.42	0.57	1.43	2.88	1.55
P/FCF Ratio	-1.07	-1.07	-0.71	-2.83	-4.34	-1.82
P/OCF Ratio	-1.08	-1.08	-0.74	-2.92	-4.57	-1.90
EV/Sales Ratio	0.26	0.01	0.12	0.51	0.75	0.33
EV/EBITDA Ratio	-0.02	-0.02	-0.31	-1.22	-4.61	-1.99
EV/EBIT Ratio	-0.02	-0.02	-0.30	-1.18	-4.29	-1.80
EV/FCF Ratio	-0.03	-0.03	-0.24	-1.46	-3.90	-1.22
Debt / Equity Ratio	0.10	0.10	0.11	0.16	0.50	0.15
Debt / EBITDA Ratio	-0.13	-0.13	-0.17	-0.26	-0.89	-0.29
Debt / FCF Ratio	-0.25	-0.25	-0.13	-0.31	-0.75	-0.18
Quick Ratio	1.62	1.62	1.72	1.68	1.72	1.62
Current Ratio	3.37	3.37	3.71	2.82	3.18	2.60
Asset Turnover	0.87	0.87	0.85	0.70	1.07	1.12
Interest Coverage	-	-	-	-540.80	-	-203.94
Return on Equity (ROE)	-75.10%	-75.10%	-72.30%	-56.60%	-39.60%	-34.30%
Return on Assets (ROA)	-32.80%	-32.80%	-33.10%	-28.20%	-22.80%	-20.60%
Return on Capital (ROIC)	-69.70%	-69.70%	-51.78%	-57.01%	-41.20%	-58.97%
Earnings Yield	-82.60%	-186.28%	-113.48%	-40.94%	-25.59%	-37.98%
FCF Yield	-41.26%	-93.05%	-141.46%	-35.30%	-23.04%	-55.08%
Buyback Yield / Dilution	-167.83%	-167.83%	-27.93%	-32.92%	-35.14%	-59.85%
Total Shareholder Return	-167.83%	-167.83%	-27.93%	-32.92%	-35.14%	-59.85%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).